325 related articles for article (PubMed ID: 19244231)
1. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.
Yoon YS; Seo WY; Lee MW; Kim ST; Koo SH
J Biol Chem; 2009 Apr; 284(16):10446-52. PubMed ID: 19244231
[TBL] [Abstract][Full Text] [Related]
2. Oxyresveratrol ameliorates nonalcoholic fatty liver disease by regulating hepatic lipogenesis and fatty acid oxidation through liver kinase B1 and AMP-activated protein kinase.
Lee JH; Baek SY; Jang EJ; Ku SK; Kim KM; Ki SH; Kim CE; Park KI; Kim SC; Kim YW
Chem Biol Interact; 2018 Jun; 289():68-74. PubMed ID: 29702089
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
5. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.
Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L
J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523
[TBL] [Abstract][Full Text] [Related]
6. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
[TBL] [Abstract][Full Text] [Related]
8. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.
Min AK; Jeong JY; Go Y; Choi YK; Kim YD; Lee IK; Park KG
Diabetologia; 2013 Feb; 56(2):412-22. PubMed ID: 23150180
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
[TBL] [Abstract][Full Text] [Related]
10. Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype.
Shen L; Cui A; Xue Y; Cui Y; Dong X; Gao Y; Yang H; Fang F; Chang Y
J Biol Chem; 2014 Aug; 289(34):23332-42. PubMed ID: 24993831
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
12. Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver.
Zhu Y; Lei L; Wang X; Jiang Q; Loor JJ; Kong F; Chen L; Li J; Zhao C; Liu M; Liu G; Li X
J Dairy Sci; 2023 Aug; 106(8):5626-5635. PubMed ID: 37291038
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone-responsive SPOT 14 homolog promotes hepatic lipogenesis, and its expression is regulated by liver X receptor α through a sterol regulatory element-binding protein 1c-dependent mechanism in mice.
Wu J; Wang C; Li S; Li S; Wang W; Li J; Chi Y; Yang H; Kong X; Zhou Y; Dong C; Wang F; Xu G; Yang J; Gustafsson JÅ; Guan Y
Hepatology; 2013 Aug; 58(2):617-28. PubMed ID: 23348573
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells.
Yang J; Craddock L; Hong S; Liu ZM
J Cell Biochem; 2009 Feb; 106(3):414-26. PubMed ID: 19125418
[TBL] [Abstract][Full Text] [Related]
15. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation.
Choi du G; Kim EK; Yang JW; Song JS; Kim YM
Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis.
Kim YW; Kim YM; Yang YM; Kim TH; Hwang SJ; Lee JR; Kim SC; Kim SG
Free Radic Biol Med; 2010 Feb; 48(4):567-78. PubMed ID: 20005944
[TBL] [Abstract][Full Text] [Related]
17. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1.
Zhao X; Feng D; Wang Q; Abdulla A; Xie XJ; Zhou J; Sun Y; Yang ES; Liu LP; Vaitheesvaran B; Bridges L; Kurland IJ; Strich R; Ni JQ; Wang C; Ericsson J; Pessin JE; Ji JY; Yang F
J Clin Invest; 2012 Jul; 122(7):2417-27. PubMed ID: 22684109
[TBL] [Abstract][Full Text] [Related]
18. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.
Li Y; Xu S; Mihaylova MM; Zheng B; Hou X; Jiang B; Park O; Luo Z; Lefai E; Shyy JY; Gao B; Wierzbicki M; Verbeuren TJ; Shaw RJ; Cohen RA; Zang M
Cell Metab; 2011 Apr; 13(4):376-388. PubMed ID: 21459323
[TBL] [Abstract][Full Text] [Related]
19. PAS kinase drives lipogenesis through SREBP-1 maturation.
Wu X; Romero D; Swiatek WI; Dorweiler I; Kikani CK; Sabic H; Zweifel BS; McKearn J; Blitzer JT; Nickols GA; Rutter J
Cell Rep; 2014 Jul; 8(1):242-55. PubMed ID: 25001282
[TBL] [Abstract][Full Text] [Related]
20. Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor.
Hansmannel F; Mordier S; Iynedjian PB
Biochem J; 2006 Oct; 399(2):275-83. PubMed ID: 16834571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
